Results
622
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
622 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €952.80 | 2.6% | 129.7% | €41.4b | €924.64 | PE60.4x | E30.5% | 0.6% | Capital Goods | ||
ALNY | US$245.20 | -1.9% | 54.2% | US$32.2b | US$304.61 | PS14.1x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$167.36 | -10.8% | 28.2% | US$52.9b | US$198.57 | PE76.6x | E41.4% | 2.7% | Diversified Financials | ||
NVDA | US$126.63 | -9.2% | 60.9% | US$3.2t | US$171.64 | PE49.2x | E21.7% | 0.03% | Semiconductors | ||
ONON | US$48.40 | -9.3% | 41.9% | US$15.6b | US$63.79 | PE109.8x | E29.8% | n/a | Consumer Durables | ||
600760 | CN¥44.25 | -1.5% | 17.4% | CN¥121.9b | CN¥53.90 | PE49.6x | E29.4% | 0.6% | Capital Goods | ||
9992 | HK$110.40 | -0.7% | 473.8% | HK$146.4b | HK$102.94 | PE89.5x | E38.1% | 0.3% | Retail | ||
6181 | HK$537.00 | 13.3% | n/a | HK$90.4b | HK$502.22 | PE104.6x | E43.2% | n/a | Consumer Durables | ||
NU | US$11.21 | -16.8% | 1.3% | US$54.0b | US$14.59 | PB7.1x | E27.9% | n/a | Banks | ||
300308 | CN¥112.22 | -1.8% | 4.9% | CN¥124.0b | CN¥192.85 | PE26.8x | E33.3% | 0.3% | Tech | ||
ALAB | US$77.74 | -16.7% | n/a | US$13.7b | US$125.03 | PS31.8x | E61.1% | n/a | Semiconductors | ||
300502 | CN¥113.00 | -6.9% | 95.0% | CN¥80.1b | CN¥161.36 | PE42x | E36.6% | 0.1% | Tech | ||
WTC | AU$96.50 | -20.7% | 2.2% | AU$32.0b | AU$125.37 | PE105.3x | E24.9% | 0.2% | Software | ||
2345 | NT$695.00 | -2.5% | 38.4% | NT$388.4b | NT$870.00 | PE39.9x | E33.7% | 1.4% | Tech | ||
A012450 | ₩672,000.00 | 5.2% | 211.0% | ₩30.6t | ₩614,150.00 | PE45.2x | E30.0% | 0.3% | Capital Goods | ||
2382 | NT$260.00 | -3.5% | 11.8% | NT$1.0t | NT$356.47 | PE18.5x | E20.7% | 3.5% | Tech | ||
A196170 | ₩393,500.00 | 1.7% | 139.2% | ₩21.0t | ₩565,000.00 | PS282x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
ITCI | US$128.58 | 0.5% | 76.4% | US$13.7b | US$132.00 | PS20.1x | E50.2% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$45.54 | -18.4% | -46.5% | US$30.2b | US$47.88 | PE22.1x | E27.6% | n/a | Tech | ||
600989 | CN¥16.20 | 1.1% | 7.5% | CN¥118.8b | CN¥21.74 | PE18.9x | E38.5% | 1.7% | Materials | ||
PME | AU$273.19 | -8.1% | 167.8% | AU$28.5b | AU$254.50 | PE290.5x | E23.6% | 0.2% | Healthcare | ||
BAM | CA$81.43 | -5.6% | 48.5% | CA$131.4b | CA$76.13 | PE169.4x | E67.5% | 3.1% | Diversified Financials | ||
SYM | US$23.45 | -15.7% | -42.4% | US$14.3b | US$34.20 | PS1.3x | E84.6% | n/a | Capital Goods | ||
BAJFINANCE | ₹8,488.80 | 0.3% | 29.5% | ₹5.3t | ₹8,664.82 | PE32.9x | E23.4% | 0.4% | Diversified Financials |